Migration Suppression of Small Cell Lung Cancer by Polysaccharides from Nostoc commune Vaucher

J Agric Food Chem. 2016 Aug 17;64(32):6277-85. doi: 10.1021/acs.jafc.6b01906. Epub 2016 Aug 3.

Abstract

Nostoc commune Vauch., classified into cyanobacteria, has been always well appreciated as a healthy food and medicine worldwide owing to its rich nutrition and potent bioactivities. Nevertheless, the inhibitory effect of polysaccharides from N. commune Vauch. (NVPS) against cancer cell progression and metastasis is still being unraveled. The results in this study showed that NVPS remarkably suppressed cell migration through blocking the epithelial-mesenchymal transition program in NCI-H446 and NCI-H1688 human small cell lung cancer cells. The inhibitory effects were attributed to the suppression of integrin β1/FAK signaling through regulating cell-matrix adhesion. Furthermore, NVPS treatment could increase E-cadherin expression, but down-regulate N-cadherin, Vimentin, and MMP-9 expression, which resulted in the blockage of STAT3 nuclear translocation and JAK1 signaling. These findings suggest that NVPS may be a good candidate for development as a possible antitumor agent against small cell lung cancer.

Keywords: Nostoc commune Vauch.; cell migration; epithelial−mesenchymal transition; polysaccharides; small cell lung cancer.

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cadherins / genetics
  • Cadherins / metabolism
  • Cell Movement / drug effects
  • Down-Regulation / drug effects
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Integrin beta1 / genetics
  • Integrin beta1 / metabolism
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / genetics
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / physiopathology*
  • Neoplasm Metastasis
  • Nostoc commune / chemistry*
  • Polysaccharides / chemistry
  • Polysaccharides / pharmacology*
  • STAT3 Transcription Factor / genetics
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction / drug effects
  • Small Cell Lung Carcinoma / drug therapy
  • Small Cell Lung Carcinoma / genetics
  • Small Cell Lung Carcinoma / metabolism
  • Small Cell Lung Carcinoma / physiopathology*
  • Vimentin / genetics
  • Vimentin / metabolism

Substances

  • Antineoplastic Agents
  • Cadherins
  • Integrin beta1
  • Polysaccharides
  • STAT3 Transcription Factor
  • Vimentin